SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-029549
Filing Date
2021-11-22
Accepted
2021-11-22 15:58:23
Documents
72
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 879525
2 ex31-1.htm EX-31.1 13228
3 ex31-2.htm EX-31.2 13207
4 ex32-1.htm EX-32.1 7671
5 ex32-2.htm EX-32.2 7600
  Complete submission text file 0001493152-21-029549.txt   4999445

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE mrzm-20210930.xsd EX-101.SCH 44138
7 XBRL CALCULATION FILE mrzm-20210930_cal.xml EX-101.CAL 55967
8 XBRL DEFINITION FILE mrzm-20210930_def.xml EX-101.DEF 159951
9 XBRL LABEL FILE mrzm-20210930_lab.xml EX-101.LAB 363384
10 XBRL PRESENTATION FILE mrzm-20210930_pre.xml EX-101.PRE 284571
11 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 681638
Mailing Address 555 HERITAGE DRIVE SUITE 205 JUPITER FL 33458
Business Address 555 HERITAGE DRIVE SUITE 205 JUPITER FL 33458 561-935-9955
MARIZYME INC (Filer) CIK: 0001413754 (see all company filings)

IRS No.: 825464863 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-53223 | Film No.: 211432472
SIC: 2834 Pharmaceutical Preparations